CH IDMP (R5)
1.0.0-ballot - trial-use
CH IDMP (R5)
1.0.0-ballot - trial-use
CH IDMP (R5) - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define constraints on FHIR resources for systems conforming to this implementation guide.
| AdministrableProductDefinition |
Profile of the AdministrableProductDefinition resource for representing a medicinal product in the final form which is suitable for administering to a patient. |
| Bundle |
Profile of the Bundle resource for representing the set of resources collected into a single package. |
| ClinicalUseDefinition Indication |
Profile of the ClinicalUseDefinition resource for representing an indication. |
| DocumentReference |
Profile of the DocumentReference resource for representing professional information and patient information as attachments. |
| Ingredient |
Profile of the Ingredient resource for representing the material used in the preparation of a medicinal/pharmaceutical product. |
| ManufacturedItemDefinition |
Profile of the ManufacturedItemDefinition resource for representing the characteristics of a medicinal manufactured item as contained in a packaged medicinal product. |
| MedicinalProductDefinition |
Profile of the MedicinalProductDefinition resource for representing the detailed data of medicinal products. |
| Organization |
Defines basic constraints and extensions on the Organization resource for use with other CH IDMP resources |
| PackagedProductDefinition |
Profile of the PackagedProductDefinition resource for representing a medically related item or items, in a container or package. |
| RegulatedAuthorization |
Profile of the RegulatedAuthorization resource for representing the market authorization of a (packaged) medicinal product. |
These define constraints on FHIR data types for systems conforming to this implementation guide.
| EMA LOC Identifier |
Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS) |
| GLN Identifier |
Identifier holding a number for GLN (Global Location Number) |
| SMC Identifier |
Identifier holding a number for Organisations registered at Swissmedic |
These define constraints on FHIR data types for systems conforming to this implementation guide.
| CH SMC - Authorized Dose Form |
Extension for representing the authorized dose form |
These define sets of codes used by systems conforming to this implementation guide.
| CH - Authorisation Type |
Value Set for Authorisation Type in Switzerland used by FOPH |
| CH - Medicinal Product Name Type |
Value Set for the Medicinal Product Name Type used in Switzerland |
| CH - Other Characteristics Type |
Value Set for Other Characteristics |
| CH Refdata - Marketing Status |
Value Set for the Marketingstatus from Refdata |
| CH SMC - Additional Monitoring Indicator |
Value Set for the Additional Monitoring Indicator from SMC |
| CH SMC - Attached Document Type |
Value Set for the Legal Status of Supply from SMC |
| CH SMC - Authorisation Category |
Value Set for the Authorisation Category from SMC |
| CH SMC - Authorisation Status |
Value Set for the Authorisation Status from SMC |
| CH SMC - Authorised Pharmaceutical Dose Form |
Value Set for the Authorised Pharmaceutical Dose Form from SMC used by FOPH |
| CH SMC - Ingredient Role |
Value Set for the Ingredient Role from SMC |
| CH SMC - Legal Status of Supply |
Value Set for the Legal Status of Supply from SMC |
| CH SMC - Marketing Status |
Value Set for the Marketingstatus from SMC |
| CH SMC - MedicinalProductCategory |
Value Set for the MedicinalProductCategory from SMC |
| CH SMC - Pediatric Use Indicator |
Value Set for the Pediatric Use Indicator from SMC |
| CH SMC - Special Precautions for Storage |
Value Set for the Special Precautions for Storage from SMC |
| CH SMC - Substance |
Value Set for the Substances from SMC |
| EDQM - Combination Packaging |
Value Set for the Combination Packaging from EDQM used by SMC |
| EDQM - Combined Pharmaceutical Dose Form |
Value Set for the Combined Pharmaceutical Dose Froms from EDQM used by SMC |
| EDQM - Combined Term |
Value Set for the Combined Terms from EDQM used by SMC |
| EDQM - Packaging |
Value Set for the Packaging from EDQM used by SMC |
| EDQM - Pharmaceutical Dose Form |
Value Set for the Pharmaceutical Dose Form |
| EDQM - Route Of Administration |
Value Set for the Route Of Administration from EDQM |
| EDQM - Unit of Presentation |
Value Set for the Unit of Presentation from EDQM used by SMC |
| EMA - Domain |
Value Set for the Domain from EMA used by SMC |
| EMA - Intended Effect |
Value Set for the Intended Effect from EMA used by SMC |
| EMA - Shelf Life Type |
Value Set for the Shelf Life Type from EMA used by SMC |
These define new code systems used by systems conforming to this implementation guide.
| CH - Authorisation Type |
CH EPL - Standard Terms used in Switzerland (aggregations of codes of ValueSets Authorisation Type |
| CH - Medicinal Product Name Type |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Typ des Arzneimittelnamens) |
| CH - Other Characteristics Type |
CH - Standard Terms to define the different other characteristics |
| CH Refdata - Marketing Status |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Vermarktungsstatus) |
| CH SMC - Additional Monitoring Indicator |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Additional Monitoring Indicator |
| CH SMC - Attached Document Type |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Typ des Anhangs) |
| CH SMC - Authorisation Category |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Authorisation Category) |
| CH SMC - Authorisation Status |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Zulassungsstatus) |
| CH SMC - Ingredient Role |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Funktion des Inhaltsstoffes) |
| CH SMC - Legal Status of Supply |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Abgabekategorie) |
| CH SMC - Marketing Status |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Vermarktungsstatus) |
| CH SMC - MedicinalProductCategory |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets MedicinalProductCategory) |
| CH SMC - Pediatric Use Indicator |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Pediatric Use Indicator) |
| CH SMC - Special Precautions for Storage |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Besondere Vorsichtsmassnahmen für die Aufbewahrung) |
| CH SMC - Substance |
CH - Standard Terms used in Switzerland (aggregations of codes of ValueSets Substanzen) |
| EDQM - Standard Terms |
EDQM - Standard Terms used in Switzerland (see original codes system defined in https://standardterms.edqm.eu/#) |
| EMA - Domain |
CH - Standard Terms used in Switzerland (aggregations of codes of Value Set for the Domain from EMA used by SMC) |
| EMA - Intended Effect |
CH - Standard Terms used in Switzerland (aggregations of codes of Value Set for the Intended Effect from EMA used by SMC) |
| EMA - Shelf Life Type |
CH - Standard Terms used in Switzerland (aggregations of codes of Value Set for the Shelf Life Type from EMA used by SMC) |
These define identifier and/or code system identities used by systems conforming to this implementation guide.
| Application / Assessment Tracking Number |
Temporary Namingsystem in this implementation guide until officially released by Swissmedic |
| Clinical Product Identifier |
Temporary Identifier in this implementation guide until officially released by Swissmedic |
| FOPH Dossier Number |
Identifier holding the Dossier number of FOPH |
| GLN Identifier |
Identifier holding a number for GLN (Global Location Number) |
| Global Trade Item Number |
GS1 defines trade items as products or services that are priced, ordered or invoiced at any point in the supply chain. |
| LOC Identifier |
Identifier holding a number for LocID (Location Identifier of the European Medicines Agency - Organisation Management System OMS) |
| Marketing Authorisation Number |
Temporary Identifier in this implementation guide until officially released by Swissmedic |
| Medical Product Identifier |
Temporary Identifier in this implementation guide until officially released by Swissmedic |
| Pharmaceutical Product Identifier |
Temporary Identifier in this implementation guide until officially released by Swissmedic |
| Swissmedic Location Identifier |
Temporary NamingSystem in this implementation guide until officially released by Swissmedic |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like.
| 123456002 |
Comprehensive Sample Combipack: Example of a RegulatedAuthorization (Marketing Authorization) |
| 12345601 |
Comprehensive Sample Combipack: Example of a RegulatedAuthorization (Marketing Authorization) |
| 67211001 |
Xospata 40 mg, Filmtabletten: Example of a RegulatedAuthorization (Marketing Authorization) |
| 6721101 |
Xospata 40 mg, Filmtabletten: Example of a RegulatedAuthorization (Marketing Authorization) |
| 68291001 |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| 68291002 |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| 6829103 |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| 6829104 |
Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| CH-56891003 |
Comprehensive Sample Combipack: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-56891003 |
Xospata 40 mg, Filmtabletten: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-68291001 |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| CH-68291002 |
Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of a PackagedProductDefinition (Packaged Medicinal Product) |
| Comprehensive Sample Combipack 20 mg Vaginal Salbe und 100 mg Vaginaltabletten |
Comprehensive Sample Combipack: Example of a MedicinalProductDefinition (Medicinal Product) |
| Comprehensive Sample Product, Creme and Pessary (Bundle) |
Comprehensive Beispiel Produkt, Creme und Vaginalzäpfchen: Example of a Bundle |
| Indication 10004055 |
Comprehensive Sample Combipack 20 mg Vaginal Salbe und 100 mg Vaginaltabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10046950 |
Comprehensive Sample Combipack 20 mg Vaginal Salbe und 100 mg Vaginaltabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10046961 |
Comprehensive Sample Combipack 20 mg Vaginal Salbe und 100 mg Vaginaltabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10050348 |
Comprehensive Sample Combipack 20 mg Vaginal Salbe und 100 mg Vaginaltabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10057352 |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung (Indication) |
| Indication 10059034 |
Xospata 40 mg, Filmtabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10060558 |
Xospata 40 mg, Filmtabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10081513 |
Xospata 40 mg, Filmtabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10081514 |
Xospata 40 mg, Filmtabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication 10084619 |
Xospata 40 mg, Filmtabletten: Example of a ClinicalUseDefinition (Indication) |
| Indication IND-10079528 |
Comprehensive Sample Combipack 20 mg Vaginal Salbe und 100 mg Vaginaltabletten: Example of a ClinicalUseDefinition (Indication) |
| MI Clindamycin-100-Pessary |
Manufactured Item definition for Clindamycin 100 Vaginal Pessary |
| MI Clindamycin-20-Cream |
Manufactured Item definition for Clindamycin 20 Vaginal Cream |
| MI Enfortumabum-vedotinum-20-Powder |
Manufactured Item definition for Enfortumabum Vedotinum 20 mg, Lyophilisate for solution for infusion |
| MI Enfortumabum-vedotinum-30-Powder |
Manufactured Item definition for Enfortumabum Vedotinum 30 mg, Lyophilisate for solution for infusion |
| MI Gilteritinibi-hemifumaras-40-Tablet |
Manufactured Item definition for Gilteritinibi Hemifumaras 40 mg, Film-coated tablet |
| PHP Enfortumabum-vedotinum-30-Solution |
Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of an AdministrableProductDefinition (Pharmaceutical Product) |
| Padcev 20 mg, Pulver Information for healthcare professionals |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of a DocumentReference |
| Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of a MedicinalProductDefinition (Medicinal Product) |
| Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung (Bundle) |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of a Bundle |
| Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of a MedicinalProductDefinition (Medicinal Product) |
| Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung (Bundle) |
Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of a Bundle |
| Patient Information Comprehensive-Sample-Combipack |
Comprehensive-Sample-Combipack: Example of a DocumentReference |
| Patient Information Xospata, Filmtabletten |
Xospata, Filmtabletten: Example of a DocumentReference |
| PhP Clindamycin-100-Pessary |
Manufactured Item definition for Clindamycin 100 Vaginal Pessary (Pharmaceutical Product) |
| PhP Clindamycin-20-Vaginal Cream |
Manufactured Item definition for Clindamycin 30 Vaginal Cream (Pharmaceutical Product) |
| PhP Enfortumabum-vedotinum-20-Solution |
Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Example of an AdministrableProductDefinition (Pharmaceutical Product) |
| PhP Gilteritinibi-hemifumaras-40-Filmtabletten |
Xospata 40 mg, Filmtabletten: Example of an AdministrableProductDefinition (Pharmaceutical Product) |
| Professional Information Comprehensive-Sample-Combipack |
Comprehensive-Sample-Combipack: Example of a DocumentReference |
| Professional Information Xospata, Filmtabletten |
Xospata, Filmtabletten: Example of a DocumentReference |
| Xospata 40 mg, Filmtabletten |
Xospata 40 mg, Filmtabletten: Example of a MedicinalProductDefinition (Medicinal Product) |
| Xospata 40 mg, Filmtabletten (Bundle) |
Xospata 40 mg, Filmtabletten: Example of a Bundle |